Zastosowanie 3-(R)-[3-[2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny do leczenia raka, a w szczególności do zapobiegania przerzutom raka i/lub leczenia
The present invention relates to the use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methyl-propyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine or one of the pharmaceutically acceptable salts thereof for treating cancer and particularly in preventing and/or treating cancerous metastases.